On May 23, there were a few penny stocks that had gapped up in the morning. So far this morning, there have been some penny stocks gapping up 10% and higher. If you are looking to trade penny stocks and get in on any potential profits today here are 4 to add to your penny stock watch list:
Two Consumer Penny Stocks to Watch
Avon Products Inc. (AVP)
Avon Products Inc. (AVP Stock Chart) is a beauty products company that sells in Europe, Latin America, Asia, and the Middle East. They offer skincare products along with fashion apparel like jewelry. If you are looking to buy penny stocks this one should make your list.
The company’s share price has increased by 15.76% premarket. The jump came from news yesterday that Avon is being acquired by Natura &Co. This would make them the 4th largest pure-play beauty group in the world.
Netshoes Limited (NETS)
Netshoes (NETS Stock Chart) is based in Brazil and sells sports and lifestyle goods to consumers. They are an online retailer which shows the company is following global consumer trends. This might be one of the best consumer penny stocks to keep your eye on.
The sports apparel company’s stock has gapped up 33% since its May 22 close. Brazilian media reported that another company, Centauro, made an offer for Netshoes. This move happened in response.
Two Healthcare Penny Stocks to Watch
Obalon Therapeutics Inc. (OBLN)
This first healthcare penny stock is based in California. They are a medical device company to treat patients who are overweight. The reason this penny stock is getting a lot of attention today is due to yesterday’s 250% gain.
Read More: One Biotechnology Penny Stock Is Up Over 100% On May 22nd; Obalon Therapeutics, Inc. (OBLN)
Again, this stock is hiking early in the morning after that massive move yesterday. Today, the company is showing an 18% premarket gap up. Both days saw gains thanks to news that they presented an expanded clinical data set for their Balloon System.
Neovasc Inc. (NVCN)
Neovasc (NVCN Stock Chart) is another medical device company. They are based out of Canada and produces the Tiara technology to treat mitral valve disease. In addition, they sell the Neovasc Reducer to help treat refractory angina.
Premarket trading has been kind to Neovasc. The stock is up 45% on good penny stock news from May 22.
That news announced a positive 2-year follow up for their Neovasc Reducer in terms of safety and efficacy.